Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-05 Purchase | 2023-05-09 8:25 pm | Eledon Pharmaceuticals Inc. | ELDN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 1,978,932 | $0 | $0 | 10,496,859 (Direct) | View |
| 2022-11-23 Purchase | 2022-11-23 4:05 pm | Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President | 1,000 | $2.5969 | $2,597 | 1,000 (Direct) | View |
| 2021-12-20 Purchase | 2021-12-21 4:05 pm | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 2,000 | $4.48 | $8,960 | 9,000 (Direct) | View |
| 2021-08-17 Purchase | 2021-08-19 4:05 pm | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 4,000 | $6.21 | $24,840 | 7,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-02 Option Award | 2023-10-03 4:19 pm | N/A 2033-10-02 | Eledon Pharmaceuticals Inc. | ELDN | Robinson James A. Jr. Director | 150,437 | $1.55 | 150,437 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-03 4:17 pm | N/A 2033-10-02 | Eledon Pharmaceuticals Inc. | ELDN | Kirk Allan Director | 150,437 | $1.55 | 150,437 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:50 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec | 179,000 | $0 | 179,000 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:50 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President | 317,147 | $0 | 317,147 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:49 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 383,299 | $0 | 383,299 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:48 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Ogier Walter C Director | 150,437 | $0 | 150,437 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:47 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Little Paul Sean Chief Financial Officer | 198,126 | $0 | 198,126 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:45 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director | 752,185 | $0 | 752,185 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:44 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | McBride John S. Director | 150,437 | $0 | 150,437 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:44 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | LYONS GARY A Director | 150,437 | $0 | 150,437 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:43 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Lee June Director | 150,437 | $0 | 150,437 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:42 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Hillson Jan Director | 150,437 | $0 | 150,437 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 6:11 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President | 155,000 | $0 | 155,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 6:10 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Ogier Walter C Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 6:08 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | McBride John S. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 6:07 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | LYONS GARY A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 6:05 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Lee June Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 6:04 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 5:58 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Hillson Jan Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 5:56 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 453,600 | $0 | 453,600 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 5:43 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec | 155,000 | $0 | 155,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 5:40 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Little Paul Sean Chief Financial Officer | 155,000 | $0 | 155,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:38 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Gros David-Alexandre C Chief Executive Officer | 108,000 | $0 | 108,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:37 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec | 120,000 | $0 | 120,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:37 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President | 155,000 | $0 | 155,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:36 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Ogier Walter C Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:35 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | McBride John S. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:33 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | LYONS GARY A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:32 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Lee June Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:30 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:29 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Hillson Jan Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:23 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Little Paul Sean Chief Financial Officer | 155,000 | $0 | 155,000 (Direct) | View |
Ownership | 2022-01-31 8:52 pm | N/A N/A | Eledon Pharmaceuticals Inc. | ELDN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 11,939,402 (Direct) | View |
Ownership | 2021-07-09 8:09 pm | N/A 2031-07-01 | Eledon Pharmaceuticals Inc. | ELDN | Hillson Jan Director | 0 | $0 | 40,000 (Direct) | View |